HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HENGRUI PHARMA

48.000

-0.440-0.91%

Volume:7.08M

Turnover:338.60M

Market Cap:318.58B

PE:34.69

High:49.100

Open:48.980

Low:46.480

Close:48.440

52wk High:90.435

52wk Low:43.020

Shares:6.64B

HK Float Shares:258.00M

Volume Ratio:1.86

T/O Rate:2.75%

Dividend:0.23

Dividend Rate:0.49%

EPS(LYR):1.384

ROE:12.46%

ROA:7.02%

PB:4.21

PE(LYR):34.69

PS:8.67

Loading ...

Overview Company News Filings

Hengrui Pharma's Growth Architecture Shifts: Second Growth Engine Accelerates as Global Valuation Framework Expands

Hengrui Pharma Gets Nod to Trial SHR-8203 Injection

MT Newswires Live

Hengrui Pharma Unit Gets China Nod for Lupus Drug Trial

MT Newswires Live

Movement Alert｜HENGRUI PHARMA Declines 3.18% in Regular Trading, Extending Sell-Off on Weak H1 Earnings Quality

Hengrui Pharmaceuticals Unit Gets China Marketing Nod for Paroxysmal Nocturnal Hemoglobinuria Drug

MT Newswires Live

Jiangsu Hengrui Pharmaceuticals- Nmpa Notice Approving Developed Class 1 Innovative Drug Licancopan Fumarate (Hrs-5965) Capsules for Marketing

THOMSON REUTERS

HENGRUI PHARMA (01276) Gets Clinical Trial Approval for SHR-7012 Injection Targeting Cutaneous Lupus Erythematosus

Jiangsu Hengrui Hong Kong Shares Hit Record Low on Quarterly Profit Miss

Movement Alert｜HENGRUI PHARMA Falls 8.55% in Regular Trading, H1 Revenue Declines as Core Profit Drops 12.7%

Hengrui Pharma Announces Resignation of Joint Company Secretary Liu Xiaohan

Bulletin Express

Hengrui Pharma Appoints Tian Fei as New Board Secretary

HENGRUI PHARMA Proposes New H-Share Incentive Scheme for 2026

Hengrui Pharma Maintains H1 2026 Profitability; Innovative Drug Sales Rise 16.4% Despite Flat Revenue

Bulletin Express

Hengrui Pharma Unveils 2026 A-Share Employee Stock Ownership Plan Valued at Approx. RMB 0.34 Billion

Bulletin Express

Hengrui Pharma's First-Half Results Unveil Strategic Shifts: From Innovative Drugs to NewCo Expansion

HENGRUI PHARMA: Wellington Management Group LLP Disposes of Shares, Long Position Falls to 5.94%

AH Share Premium Rankings: August 19 Market Close Analysis

Movement Alert｜HENGRUI PHARMA Falls 3.19% in Regular Trading, Cautious Earnings Outlook and Sector Weakness Weigh on Shares

Hengrui Pharma Gets China Nod For Inflammatory Bowel Injection Clinical Trial

MT Newswires Live

Hengrui Pharma Gets China Nod For Phase II Diabetes Drug Trial

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/01276/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01276","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","market":"HK","secType":"STK","nameCN":"HENGRUI PHARMA","latestPrice":48,"timestamp":1791533288000,"preClose":48.44,"halted":0,"volume":7084600,"delay":0,"changeRate":-0.009083402146985916,"floatShares":258000000,"shares":6637000000,"eps":1.3837490681085154,"marketStatus":"Closed","change":-0.44,"latestTime":"10-09 16:08:08","open":48.98,"high":49.1,"low":46.48,"amount":338603291,"amplitude":0.054088,"askPrice":48,"askSize":1600,"bidPrice":47.98,"bidSize":800,"shortable":3,"etf":0,"ttmEps":1.3646228415823713,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791768600000},"marketStatusCode":5,"adr":0,"listingDate":1747929600000,"exchange":"SEHK","adjPreClose":48.44,"dividendRate":0.004874,"openAndCloseTimeList":[[1791509400000,1791518400000],[1791522000000,1791532800000]],"volumeRatio":1.864942,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600276","market":"SH","secType":"STK","nameCN":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd.","latestPrice":46.85,"timestamp":1791529200000,"preClose":47.01,"halted":0,"volume":62812700,"delay":0,"premium":"-12.63"}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","floatShares":258000000,"roa":"7.02%","roe":"12.46%","lyrEps":1.383749,"volumeRatio":1.864942,"shares":6637000000,"dividePrice":0.234534,"high":49.1,"amplitude":0.054088,"preClose":48.44,"low":46.48,"week52Low":43.02,"pbRate":"4.21","psRate":"8.67","week52High":90.435,"institutionHeld":0,"latestPrice":48,"committee":-0.333333,"eps":1.3837490681085154,"divideRate":0.004886,"volume":7084600,"delay":0,"ttmEps":1.3646228415823713,"open":48.98,"prevYearClose":71.002,"prevWeekClose":49.66,"prevMonthClose":50.2,"prevQuarterClose":50.2,"fiveDayClose":49.66,"twentyDayClose":43.96,"sixtyDayClose":57.95,"earningDate":1793116800000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01276\",params:#limit:5,,,undefined,":[{"date":"2026-10-28","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1793151000000,"name":null,"time":"","dateTimestamp":1793116800000,"actualEps":null},{"date":"2026-08-19","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787103000000,"name":null,"time":"","dateTimestamp":1787068800000,"actualEps":null},{"date":"2026-04-29","symbol":"01276","amount":0.22828,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2026-04-30","defaultRemindTime":1777426200000,"name":"恒瑞医药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-27","payableDate":"2026-04-30","currency":"HKD","dateTimestamp":1777392000000,"payDate":"2026-05-27"},{"date":"2026-04-22","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1776821400000,"name":null,"time":"","dateTimestamp":1776787200000,"actualEps":null},{"date":"2026-03-26","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774488600000,"name":null,"time":"","dateTimestamp":1774454400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01276\",market:\"HK\",,,undefined,":[{"executeDate":"2026-04-29","recordDate":"2026-04-30","paymentDate":"2026-05-27","value":0.22828,"currency":"HKD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01276\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.2727,"buy":0.5455,"hold":0.1818,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5455,"analysts":11,"updateTime":1786723200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01276\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01276","date":"2026-10-08","current":35.174554,"percent":0.120235,"low":36.382401,"twenty":42.928092,"median":51.24762,"eighty":56.79448,"high":65.582363,"avg":50.547368,"sd":7.720082,"marketCap":362492038311.23},"quantilePoints":[{"date":"2025-05-23","current":52.570963,"twenty":52.783176,"median":53.101495,"eighty":53.419815,"marketCap":390693388207.53},{"date":"2025-05-30","current":53.015805,"twenty":51.822085,"median":52.540895,"eighty":52.926837,"marketCap":395731540422.24},{"date":"2025-06-06","current":52.120101,"twenty":52.130014,"median":52.555929,"eighty":53.075252,"marketCap":390038198012.59},{"date":"2025-06-13","current":52.209491,"twenty":52.177631,"median":52.691227,"eighty":53.357137,"marketCap":390861633032.23},{"date":"2025-06-20","current":50.172412,"twenty":51.591196,"median":52.469796,"eighty":53.075252,"marketCap":374874997562.85},{"date":"2025-06-27","current":50.314776,"twenty":50.363569,"median":52.169666,"eighty":53.013533,"marketCap":376991477472.78},{"date":"2025-07-04","current":51.666141,"twenty":50.343584,"median":52.120101,"eighty":53.004446,"marketCap":387134991658.26},{"date":"2025-07-11","current":55.507007,"twenty":50.44351,"median":52.13337,"eighty":53.090114,"marketCap":415495681161.23},{"date":"2025-07-18","current":57.272274,"twenty":50.582121,"median":52.209491,"eighty":54.057606,"marketCap":428373566715.29},{"date":"2025-07-25","current":54.897923,"twenty":50.594414,"median":52.555929,"eighty":55.711415,"marketCap":412107620053.2},{"date":"2025-08-01","current":59.731878,"twenty":50.855059,"median":52.994419,"eighty":55.972407,"marketCap":445624526286.47},{"date":"2025-08-08","current":59.478715,"twenty":51.107295,"median":53.05296,"eighty":56.541585,"marketCap":444845815775.64},{"date":"2025-08-15","current":61.917611,"twenty":51.356483,"median":53.519848,"eighty":59.478715,"marketCap":462392609292.46},{"date":"2025-08-22","current":58.782188,"twenty":51.569512,"median":54.477764,"eighty":60.15932,"marketCap":470428104569.66},{"date":"2025-08-29","current":59.85298,"twenty":51.666141,"median":55.691374,"eighty":59.937003,"marketCap":481284287403.35},{"date":"2025-09-05","current":65.582363,"twenty":51.677932,"median":55.770266,"eighty":60.732448,"marketCap":526832269752.24},{"date":"2025-09-12","current":62.481332,"twenty":51.8337,"median":55.972407,"eighty":61.285609,"marketCap":502824785657.99},{"date":"2025-09-19","current":63.179889,"twenty":52.120101,"median":56.254853,"eighty":61.852995,"marketCap":508085671393.42},{"date":"2025-09-26","current":63.528382,"twenty":52.146639,"median":56.965096,"eighty":62.270337,"marketCap":509562668601.01},{"date":"2025-10-03","current":64.989073,"twenty":52.165061,"median":57.272274,"eighty":62.504861,"marketCap":522523002865.02},{"date":"2025-10-10","current":61.782766,"twenty":52.193561,"median":59.039802,"eighty":62.657943,"marketCap":496019912951.91},{"date":"2025-10-17","current":58.903713,"twenty":52.323014,"median":59.170669,"eighty":62.619084,"marketCap":472537436949.31},{"date":"2025-10-24","current":59.187086,"twenty":52.484015,"median":59.039802,"eighty":62.52839,"marketCap":474983377696.11},{"date":"2025-10-31","current":57.072441,"twenty":52.552922,"median":59.021138,"eighty":62.417499,"marketCap":465758305542.93},{"date":"2025-11-07","current":54.713071,"twenty":52.619069,"median":58.881843,"eighty":62.304573,"marketCap":446224987036.64},{"date":"2025-11-14","current":55.883072,"twenty":52.812504,"median":58.231971,"eighty":62.27542,"marketCap":457058673340.29},{"date":"2025-11-21","current":52.805265,"twenty":52.880927,"median":57.030538,"eighty":62.209511,"marketCap":431684582485.14},{"date":"2025-11-28","current":55.237621,"twenty":52.99843,"median":56.630614,"eighty":62.069705,"marketCap":453209419829.34},{"date":"2025-12-05","current":54.841023,"twenty":53.00899,"median":56.437545,"eighty":61.965159,"marketCap":450729029423.46},{"date":"2025-12-12","current":56.212257,"twenty":53.045529,"median":56.385682,"eighty":61.891765,"marketCap":462853512587.19},{"date":"2025-12-19","current":54.083493,"twenty":53.045529,"median":56.227363,"eighty":61.831221,"marketCap":446374731108.34},{"date":"2025-12-24","current":54.414957,"twenty":53.090114,"median":56.103073,"eighty":61.798561,"marketCap":450509359276.9},{"date":"2026-01-02","current":53.078544,"twenty":53.065996,"median":55.972407,"eighty":61.785925,"marketCap":441174507319.22},{"date":"2026-01-09","current":56.743223,"twenty":53.0878,"median":56.0944,"eighty":61.695241,"marketCap":472808676524.34},{"date":"2026-01-16","current":55.187351,"twenty":53.304215,"median":56.103073,"eighty":61.405393,"marketCap":461338821289.95},{"date":"2026-01-23","current":52.546341,"twenty":53.0878,"median":56.076447,"eighty":61.296167,"marketCap":438839874056.97},{"date":"2026-01-30","current":51.677141,"twenty":52.994149,"median":55.908509,"eighty":61.278475,"marketCap":433553740508.2},{"date":"2026-02-06","current":50.918226,"twenty":52.680723,"median":55.839154,"eighty":61.101743,"marketCap":428270226283.58},{"date":"2026-02-13","current":51.771686,"twenty":52.512455,"median":55.711415,"eighty":60.890064,"marketCap":437949787160.49},{"date":"2026-02-20","current":51.752043,"twenty":52.351169,"median":55.691374,"eighty":60.824953,"marketCap":437153052005.04},{"date":"2026-02-27","current":50.215456,"twenty":52.151244,"median":55.507566,"eighty":60.720339,"marketCap":428825318404.97},{"date":"2026-03-06","current":49.335298,"twenty":51.80347,"median":55.280584,"eighty":60.654676,"marketCap":417912584744.19},{"date":"2026-03-13","current":48.90444,"twenty":51.75217,"median":55.201025,"eighty":60.572606,"marketCap":416170839186.33},{"date":"2026-03-20","current":48.948437,"twenty":51.671435,"median":55.086674,"eighty":60.515374,"marketCap":414967977646.95},{"date":"2026-03-27","current":47.483832,"twenty":51.400677,"median":54.94883,"eighty":60.443129,"marketCap":414588875872.42},{"date":"2026-04-02","current":49.302243,"twenty":51.107295,"median":54.905743,"eighty":60.227005,"marketCap":432534434303.11},{"date":"2026-04-10","current":49.055344,"twenty":50.995993,"median":54.897923,"eighty":60.186394,"marketCap":433687668394.36},{"date":"2026-04-17","current":48.417764,"twenty":50.589497,"median":54.65026,"eighty":60.143018,"marketCap":428230701835.75},{"date":"2026-04-24","current":45.835792,"twenty":50.342877,"median":54.475147,"eighty":60.015062,"marketCap":426879682872.04},{"date":"2026-04-30","current":44.026312,"twenty":50.285416,"median":54.355253,"eighty":59.903394,"marketCap":410132737659.64},{"date":"2026-05-08","current":43.161515,"twenty":50.207478,"median":54.262074,"eighty":59.804539,"marketCap":403472171949.3},{"date":"2026-05-15","current":44.128138,"twenty":49.985706,"median":54.115335,"eighty":59.70386,"marketCap":413593092820.6},{"date":"2026-05-22","current":41.244553,"twenty":49.583265,"median":53.983854,"eighty":59.631568,"marketCap":385683097978.4},{"date":"2026-05-29","current":40.98659,"twenty":49.34142,"median":53.840414,"eighty":59.564678,"marketCap":384603594259.51},{"date":"2026-06-05","current":38.394132,"twenty":49.063316,"median":53.633194,"eighty":59.459458,"marketCap":360799766229.36},{"date":"2026-06-12","current":39.515262,"twenty":48.81081,"median":53.517715,"eighty":59.36625,"marketCap":371084155232.86},{"date":"2026-06-18","current":39.444808,"twenty":48.417764,"median":53.467699,"eighty":59.301536,"marketCap":371311256576.18},{"date":"2026-06-26","current":39.60241,"twenty":47.951326,"median":53.090114,"eighty":59.187086,"marketCap":370974287810.31},{"date":"2026-07-03","current":44.319925,"twenty":47.638943,"median":53.015805,"eighty":59.069259,"marketCap":415476044901.86},{"date":"2026-07-10","current":45.319748,"twenty":47.348429,"median":52.993744,"eighty":59.024871,"marketCap":424327469311.14},{"date":"2026-07-17","current":43.189222,"twenty":46.151454,"median":52.805265,"eighty":58.96135,"marketCap":405818502739.33},{"date":"2026-07-24","current":43.433009,"twenty":45.632553,"median":52.604835,"eighty":58.912251,"marketCap":408200902707.63},{"date":"2026-07-31","current":43.935338,"twenty":45.29749,"median":52.543618,"eighty":58.877468,"marketCap":413706414238.87},{"date":"2026-08-07","current":44.394532,"twenty":45.008473,"median":52.339287,"eighty":58.813302,"marketCap":418841988303.56},{"date":"2026-08-14","current":42.6704,"twenty":44.628794,"median":52.189578,"eighty":58.452058,"marketCap":403085247281.44},{"date":"2026-08-21","current":40.686911,"twenty":44.408765,"median":52.120101,"eighty":57.75211,"marketCap":366558497066.13},{"date":"2026-08-28","current":40.334802,"twenty":44.24321,"median":51.814807,"eighty":57.336246,"marketCap":363468645736.13},{"date":"2026-09-04","current":39.220129,"twenty":44.050964,"median":51.771686,"eighty":57.152374,"marketCap":353565883607.49},{"date":"2026-09-11","current":36.382401,"twenty":43.912617,"median":51.717719,"eighty":57.022157,"marketCap":328426636361.34},{"date":"2026-09-18","current":37.472943,"twenty":43.707258,"median":51.677141,"eighty":56.974512,"marketCap":338713028678.65},{"date":"2026-09-25","current":38.226655,"twenty":43.43262,"median":51.617827,"eighty":56.891919,"marketCap":344867204477.93},{"date":"2026-10-02","current":40.279147,"twenty":43.172598,"median":51.438629,"eighty":56.828798,"marketCap":363767175425.28},{"date":"2026-10-08","current":40.08793,"twenty":42.928092,"median":51.24762,"eighty":56.79448,"marketCap":362492038311.23}],"updateTime":1791547456883},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01276\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1157060014","title":"Hengrui Pharma's Growth Architecture Shifts: Second Growth Engine Accelerates as Global Valuation Framework Expands","url":"https://stock-news.laohu8.com/highlight/detail?id=1157060014","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157060014?lang=en_us&edition=fundamental","pubTime":"2026-08-23 21:06","pubTimestamp":1787490393,"startTime":"0","endTime":"0","summary":"On August 19, Hengrui Pharma (01276) delivered a resilient first-half earnings report. During the period, the company recorded operating revenue of RMB 15.456 billion, with net profit attributable to...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1781817850.SGD","BK0183","BK0196","LU1064130708.USD","LU1969619763.USD","LU1997245177.USD","LU2097828805.USD","LU0405327148.USD","LU1146622755.USD","LU1997244956.HKD","LU2328871848.SGD","BK1191","LU2488822045.USD","LU1580142542.USD","LU2580892789.USD","LU0359201612.USD","LU2495084118.USD","LU2097828474.EUR","LU0359201885.HKD","LU2097828557.USD","LU0359202008.SGD","01276","BK0239","LU0405327494.USD","LU1023057109.AUD","LU1255011170.USD","LU2097828631.EUR","BK0028","LU1655091616.SGD","LU2148510915.USD","600276","LU2097828714.EUR","BK0188","BK0012","BK0060","LU2289578879.USD","LU2580892862.HKD","LU1064131003.USD","LU1328615791.USD","LU2543165471.USD","LU1820825898.SGD","LU1997245094.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661212256","title":"Hengrui Pharma Gets Nod to Trial SHR-8203 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2661212256","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661212256?lang=en_us&edition=fundamental","pubTime":"2026-08-21 10:08","pubTimestamp":1787278105,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals  received approval from China's National Medical Products Administration for the clinical trial of SHR-8203 injection, according to a Shanghai bourse filing on Friday.The drug will be tested as a monotherapy for advanced solid tumors.The Chinese pharmaceutical company's Shanghai shares dropped 3% during the morning trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2543165471.USD","BK1191","LU1023057109.AUD","LU0359201612.USD","01276","LU0359202008.SGD","LU0359201885.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661256285","title":"Hengrui Pharma Unit Gets China Nod for Lupus Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2661256285","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661256285?lang=en_us&edition=fundamental","pubTime":"2026-08-21 10:05","pubTimestamp":1787277919,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals  (SHA:600276) unit Guangdong Hengrui Medicine obtained approval from China's drug regulator to begin clinical trials for SHR-7012 injection.SHR-7012 targets cutaneous lupus erythematosus, according to a Thursday aftermarket filing.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0359202008.SGD","LU1023057109.AUD","LU0359201885.HKD","LU2543165471.USD","01276","BK1191","LU0359201612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175051703","title":"Movement Alert｜HENGRUI PHARMA Declines 3.18% in Regular Trading, Extending Sell-Off on Weak H1 Earnings Quality","url":"https://stock-news.laohu8.com/highlight/detail?id=1175051703","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175051703?lang=en_us&edition=fundamental","pubTime":"2026-08-21 09:42","pubTimestamp":1787276522,"startTime":"0","endTime":"0","summary":"On August 21, HENGRUI PHARMA declined 3.18% in regular trading, trading at 47.66 HKD/share with turnover of approximately 109 million HKD, extending the prior session's 8.55% selloff.The decline...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Hengrui Pharma Extends Decline on Weak Cash Flow and Core Profit","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660282560","title":"Hengrui Pharmaceuticals Unit Gets China Marketing Nod for Paroxysmal Nocturnal Hemoglobinuria Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2660282560","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660282560?lang=en_us&edition=fundamental","pubTime":"2026-08-20 20:48","pubTimestamp":1787230129,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals  unit Chengdu Suncadia Medicine obtained marketing approval for its Licancopan Fumarate Capsules from China's National Medical Products Administration.The approved indication is for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria  who have not previously received complement inhibitor therapy, according to a Thursday bourse filing.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2543165471.USD","BK1191","LU0359201612.USD","LU0359202008.SGD","01276","LU1023057109.AUD","LU0359201885.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660285347","title":"Jiangsu Hengrui Pharmaceuticals- Nmpa Notice Approving Developed Class 1 Innovative Drug Licancopan Fumarate (Hrs-5965) Capsules for Marketing","url":"https://stock-news.laohu8.com/highlight/detail?id=2660285347","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660285347?lang=en_us&edition=fundamental","pubTime":"2026-08-20 18:31","pubTimestamp":1787221884,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nFWN44H0I8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1023057109.AUD","BK0196","LU2097828557.USD","LU2328871848.SGD","BK0060","LU2495084118.USD","LU2097828805.USD","LU2488822045.USD","LU2580892862.HKD","LU0359201885.HKD","LU2543165471.USD","LU1255011170.USD","LU1064131003.USD","LU1969619763.USD","LU1997245094.SGD","LU2097828714.EUR","LU1997245177.USD","LU0405327494.USD","LU1820825898.SGD","LU2580892789.USD","LU1655091616.SGD","LU1328615791.USD","LU0359202008.SGD","BK1191","BK0012","LU0405327148.USD","LU2148510915.USD","01276","600276","LU1580142542.USD","LU0359201612.USD","BK0239","LU1781817850.SGD","LU2097828631.EUR","LU1064130708.USD","LU2097828474.EUR","BK0183","LU1997244956.HKD","LU1146622755.USD","LU2289578879.USD","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130698825","title":"HENGRUI PHARMA (01276) Gets Clinical Trial Approval for SHR-7012 Injection Targeting Cutaneous Lupus Erythematosus","url":"https://stock-news.laohu8.com/highlight/detail?id=1130698825","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130698825?lang=en_us&edition=fundamental","pubTime":"2026-08-20 18:26","pubTimestamp":1787221594,"startTime":"0","endTime":"0","summary":"HENGRUI PHARMA (01276) has announced that its subsidiary, Guangdong Hengrui Pharmaceuticals Co., Ltd., has received the Drug Clinical Trial Approval Notice issued by the National Medical Products...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1655091616.SGD","LU2097828474.EUR","LU2097828557.USD","IBBQ","BK0028","LU2328871848.SGD","LU0359202008.SGD","LU1023057109.AUD","PSYK","LU1969619763.USD","LU1997245094.SGD","LU1580142542.USD","LU0359201885.HKD","LU1997244956.HKD","LU0359201612.USD","LU1064131003.USD","LU1781817850.SGD","LU2488822045.USD","LU1255011170.USD","LU2148510915.USD","LU2097828714.EUR","BK1191","BK0183","LU2289578879.USD","LU2495084118.USD","LU1064130708.USD","01276","IBBJ","LU1146622755.USD","LU0405327148.USD","BK0239","LU2580892789.USD","MDTX","BK0196","LU2097828805.USD","LU1820825898.SGD","LU2580892862.HKD","LU2543165471.USD","BK0012","BK0188","LU1997245177.USD","LU2097828631.EUR","BMED","LU0405327494.USD","600276","LU1328615791.USD","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660118408","title":"Jiangsu Hengrui Hong Kong Shares Hit Record Low on Quarterly Profit Miss","url":"https://stock-news.laohu8.com/highlight/detail?id=2660118408","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660118408?lang=en_us&edition=fundamental","pubTime":"2026-08-20 12:20","pubTimestamp":1787199653,"startTime":"0","endTime":"0","summary":"BUZZ-Jiangsu Hengrui Hong Kong shares hit record low on quarterly profit miss** Hong Kong shares of Jiangsu Hengrui Pharmaceuticals1276.HKdrop 11.2% to HK$48.8, record low since debut in May 2025** St","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL1N44H03J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828631.EUR","LU2495084118.USD","LU1997244956.HKD","600276","LU0405327494.USD","BK0012","BK1191","LU1969619763.USD","LU1997245177.USD","LU2328871848.SGD","LU1023057109.AUD","LU2580892862.HKD","BK0028","LU0359201612.USD","BK0188","BK0239","LU1328615791.USD","01276","LU2097828557.USD","LU2289578879.USD","LU1146622755.USD","BK0060","LU0359201885.HKD","LU1655091616.SGD","LU1820825898.SGD","LU2097828805.USD","LU2097828474.EUR","LU2488822045.USD","BK0196","LU2097828714.EUR","LU2580892789.USD","LU1580142542.USD","LU1997245094.SGD","LU1781817850.SGD","LU2148510915.USD","LU1255011170.USD","LU0359202008.SGD","BK0183","LU2543165471.USD","LU1064130708.USD","LU0405327148.USD","LU1064131003.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148990473","title":"Movement Alert｜HENGRUI PHARMA Falls 8.55% in Regular Trading, H1 Revenue Declines as Core Profit Drops 12.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1148990473","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148990473?lang=en_us&edition=fundamental","pubTime":"2026-08-20 09:33","pubTimestamp":1787189623,"startTime":"0","endTime":"0","summary":"On August 20, HENGRUI PHARMA fell 8.55% in regular trading, trading at HK$50.85/share, with turnover of HK$109 million. The selloff was triggered by the company's disappointing first-half earnings...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"HENGRUI PHARMA Falls as H1 Revenue Declines as Core Profit Drops 12.7%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171904948","title":"Hengrui Pharma Announces Resignation of Joint Company Secretary Liu Xiaohan","url":"https://stock-news.laohu8.com/highlight/detail?id=1171904948","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171904948?lang=en_us&edition=fundamental","pubTime":"2026-08-19 22:29","pubTimestamp":1787149741,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (“Hengrui Pharma”) disclosed that Ms. Liu Xiaohan resigned from her position as joint company secretary, effective 19 August 2026. According to the board,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185153566","title":"Hengrui Pharma Appoints Tian Fei as New Board Secretary","url":"https://stock-news.laohu8.com/highlight/detail?id=1185153566","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185153566?lang=en_us&edition=fundamental","pubTime":"2026-08-19 22:22","pubTimestamp":1787149332,"startTime":"0","endTime":"0","summary":"Hengrui Pharma (01276) has announced a key executive change, with the appointment of Tian Fei as the company's new Board Secretary.The decision was formally ratified during the fourth meeting of the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828557.USD","LU2097828631.EUR","LU0359202008.SGD","LU0405327494.USD","LU2289578879.USD","LU2148510915.USD","LU2580892789.USD","LU1064131003.USD","LU2097828714.EUR","LU0405327148.USD","LU1064130708.USD","BK0012","LU2097828805.USD","LU2543165471.USD","LU1997244956.HKD","BK0188","BK1191","LU0359201885.HKD","LU1655091616.SGD","LU1997245177.USD","LU2097828474.EUR","LU1146622755.USD","LU2488822045.USD","LU1820825898.SGD","LU2495084118.USD","LU2580892862.HKD","LU1997245094.SGD","BK0028","BK0060","LU0359201612.USD","LU1781817850.SGD","LU1969619763.USD","LU2328871848.SGD","LU1255011170.USD","BK0183","BK0196","BK0239","LU1023057109.AUD","01276","LU1580142542.USD","600276","LU1328615791.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139277418","title":"HENGRUI PHARMA Proposes New H-Share Incentive Scheme for 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1139277418","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139277418?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:52","pubTimestamp":1787147541,"startTime":"0","endTime":"0","summary":"HENGRUI PHARMA (01276) announced that on August 19, 2026, its board has resolved to recommend the adoption of the 2026 H-Share Share Plan.The plan will take effect upon approval at the upcoming first extraordinary general meeting of the company in 2026.","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1781817850.SGD","BK0183","BK0196","LU1064130708.USD","LU1969619763.USD","LU1997245177.USD","LU2097828805.USD","LU0405327148.USD","LU1146622755.USD","LU1997244956.HKD","LU2328871848.SGD","BK1191","LU2488822045.USD","LU1580142542.USD","LU2580892789.USD","LU0359201612.USD","LU2495084118.USD","LU2097828474.EUR","LU0359201885.HKD","LU2097828557.USD","LU0359202008.SGD","01276","BK0239","LU0405327494.USD","LU1023057109.AUD","LU1255011170.USD","LU2097828631.EUR","BK0028","LU1655091616.SGD","LU2148510915.USD","600276","LU2097828714.EUR","BK0188","BK0012","BK0060","LU2289578879.USD","LU2580892862.HKD","LU1064131003.USD","LU1328615791.USD","LU2543165471.USD","LU1820825898.SGD","LU1997245094.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196895712","title":"Hengrui Pharma Maintains H1 2026 Profitability; Innovative Drug Sales Rise 16.4% Despite Flat Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=1196895712","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196895712?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:46","pubTimestamp":1787147187,"startTime":"0","endTime":"0","summary":"Hengrui Pharma reported first-half 2026 revenue of RMB 15.46 billion, edging down 1.9% year on year as lower licensing receipts offset higher product sales. Gross profit slipped 2.2% to RMB 13.34...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Hengrui Pharma Maintains H1 2026 Profitability; Innovative Drug Sales Rise 16.4% Despite Flat Revenue","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100417660","title":"Hengrui Pharma Unveils 2026 A-Share Employee Stock Ownership Plan Valued at Approx. RMB 0.34 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1100417660","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100417660?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:46","pubTimestamp":1787147163,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) has approved a new 2026 A-share Employee Stock Ownership Scheme (ESOS), pending shareholder approval at an upcoming extraordinary general...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178000037","title":"Hengrui Pharma's First-Half Results Unveil Strategic Shifts: From Innovative Drugs to NewCo Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=1178000037","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178000037?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:08","pubTimestamp":1787141307,"startTime":"0","endTime":"0","summary":"On August 19, Hengrui Pharma (01276) released its 2026 semi-annual report. During the reporting period, the company achieved operating revenue of RMB 15.456 billion, with product sales revenue of RMB...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","LU2488822045.USD","BK0028","LU1655091616.SGD","LU1997245094.SGD","LU0359202008.SGD","01276","LU2097828714.EUR","LU2580892789.USD","BK1161","BK0188","LU1064130708.USD","LU1255011170.USD","BK0183","BK1574","LU2097828805.USD","LU1146622755.USD","LU2543165471.USD","600276","LNGR","IBBQ","LU2097828557.USD","BK0196","LU2328871848.SGD","MEDX","LU0405327494.USD","LU1328615791.USD","LU2289578879.USD","LU0359201885.HKD","BK0060","LU1023057109.AUD","BK1191","LU1997244956.HKD","LU2148510915.USD","LU1969619763.USD","LU1580142542.USD","BK0012","LU2097828631.EUR","LU1064131003.USD","LU2580892862.HKD","BK0239","LU1820825898.SGD","LU2097828474.EUR","LU2495084118.USD","LU1781817850.SGD","LU1997245177.USD","06978","LU0405327148.USD","LU0359201612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170305883","title":"HENGRUI PHARMA: Wellington Management Group LLP Disposes of Shares, Long Position Falls to 5.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=1170305883","media":"HK Disclosure","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170305883?lang=en_us&edition=fundamental","pubTime":"2026-08-19 17:12","pubTimestamp":1787130761,"startTime":"0","endTime":"0","summary":"On August 14, 2026, Wellington Management Group LLP sold 1.07 million shares of HENGRUI PHARMA (H shares) at an average of HKD 52.7484 per share, involving about HKD 56.20 million.Prior to the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170866253","title":"AH Share Premium Rankings: August 19 Market Close Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=1170866253","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170866253?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:16","pubTimestamp":1787127414,"startTime":"0","endTime":"0","summary":"Data from the August 19 market close reveals notable shifts in the A-H share premium landscape. NE ELECTRIC (00042), ZHEJIANG SHIBAO (01057), and ANDRE JUICE (02218) hold the top three positions for...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2476274720.SGD","LU0117841782.USD","LU1044876610.USD","LU0384037296.USD","LU0039217434.USD","LU1244550221.USD","LU2125910500.SGD","BK1122","LU0672654166.SGD","LU1831875114.USD","LU0918141705.HKD","06951","LU1688375341.USD","LU2242644610.SGD","LU0821914370.USD","BK1551","LU0197773673.USD","LU2294711473.HKD","LU1044874839.SGD","LU1808992512.USD","159982","LU0231483743.USD","LU0266512127.USD","02768","LU0651946864.USD","LU2476274308.USD","LU0449515922.USD","LU0516422952.EUR","LU0329678337.USD","LU1023057109.AUD","BK1554","LU0082770016.SGD","LU0117844026.USD","LU0828237940.HKD","LU0054450605.USD","LU0244354667.USD","IE00B031HY20.USD","LU0106252389.USD","LU0531970944.HKD","EWH","LU0043850808.USD","BK1144","BK1562","LU1244550494.USD","BK1594","LU0287142896.SGD","LU1051768304.USD","LU0314109678.HKD","IE00BZ08YS42.EUR","LU1366334578.USD","LU3063872942.SGD","LU0862451753.SGD","BK1105","LU2153592121.USD","BK1237","02691","02846","LU0051755006.USD","LU2348774022.SGD","BK1514","LU0878005551.USD","LU0819123356.HKD","LU0164880469.USD","LU0345780281.USD","BK1147","LU0634319403.HKD","HPAD.SI","LU0266512473.USD","LU0878004406.USD","LU0049853897.USD","LU0463099449.HKD","LU0456827905.SGD","LU2152927971.USD","LU2226246903.HKD","LU1048596156.SGD","SG9999001093.SGD","LU0890818403.SGD","BK1526","LU2663582299.SGD","LU0791590937.USD","HK0000352291.HKD","LU0229945570.USD","00187","HK0000286598.CNH","LU0128522157.USD","LU0348825331.USD","LU1048588211.SGD","BK1186","03268","02318","PNGAY","BK1583","BK1191","IE00B5MMRT66.SGD","LU0315179316.USD","LU0640798160.USD","LU1226287529.USD","LU1807302812.USD","LU0235996351.USD","LU2264538146.SGD","LU0061477393.USD","LU1820825898.SGD","00553","LU1769817179.HKD","LU1988902786.USD","LU0865486749.SGD","LU0164939612.USD","LU0370786039.SGD","LU0708995583.HKD","LU0762541174.USD","LU0862451837.USD","LU2424517915.HKD","IE0034224299.USD","03759","LU0011963245.USD","LU0871576103.HKD","BK1564","IE00B3M56506.USD","LU0165289439.USD","LU0488056044.USD","LU0868486357.SGD","LU0210526637.USD","LU0823426308.USD","LU0197773160.USD","LU0307460666.USD","03200","IE00B543WZ88.USD","LU2045819591.USD","LU2008162690.USD","LU0594300179.USD","LU0417516571.SGD","LU1960683339.HKD","83188","LU0067412154.USD","LU0509642566.USD","LU0651947912.USD","BK1560","LU0823426480.USD","LU1981816686.USD","01812","LU1481107354.HKD","LU1769817096.USD","BK1592","LU0348784397.USD","LU1880383366.USD","BK1546","LU0084288322.USD","LU0417516738.SGD","LU0326950275.SGD","LU0882747503.HKD","SG9999001903.USD","LU0516422440.USD","LU0502904849.HKD","LU0880133367.SGD","SG9999014674.SGD","BK1183","LU0441854154.USD","LU0431992006.USD","SG9999006597.SGD","LU0164865239.USD","03986","BK1202","BK1170","HK0000306701.USD","LU0359201885.HKD","LU0211977185.USD","IE00B29SXG58.USD","IE00BZ08YR35.GBP","83130","LU0293314216.USD","LU1282651048.USD","IE00BGHQDM52.EUR","LU2293587155.HKD","IE00B0169L03.USD","IE0003895053.USD","LU0173614495.USD","LU0675040207.SGD","LU1115378108.SGD","SG9999011746.SGD","LU1224444064.USD","LU1282649810.SGD","LU2153591404.USD","LU0449509016.USD","LU0417516902.SGD","LU0072462343.USD","LU0594300419.USD","LU0607220059.USD","LU0593848301.USD","IE0008368742.USD","BK1558","LU0561508036.HKD","00668","LU1242518931.SGD","LU0196878994.USD","IE0008369823.USD","LU0630378692.HKD","LU0320764755.SGD","LU0540923850.HKD","BK1567","PAImain","BK1249","BK1522","LU0588546209.SGD","LU0348766576.USD","LU0106959298.USD","LU0163747925.USD","LU1515016050.SGD","LU0856984785.SGD","HK0000151867.HKD","IE00BYV24P56.USD","LU0214875030.USD","03143","LU0831093199.SGD","LU1282648689.USD","BK1576","LU0149721374.USD","LU0348735423.USD","01108","BK1507","LU2543165471.USD","LU1366334651.USD","LU0329678170.USD","LU0886674414.USD","LU1328277881.USD","LU2778985437.USD","03145","BK1198","LU1508157978.USD","LU1152091754.HKD","BK1550","03130","LU1224709979.USD","LU0315178854.USD","LU1655091459.SGD","LU0589944569.HKD","03968","HK0000320264.USD","LU0072913022.USD","LU0898667661.SGD","01033","LU1770034418.SGD","02338","LU0516422366.SGD","LU0979878070.USD","01776","LU0254981946.USD","LU1051769294.HKD","SG9999002828.SGD","00317","BK1240","IE00BVYPNP33.GBP","LU1251922891.USD","LU1105468828.SGD","LU0228659784.USD","BK1190","LU0543330483.HKD","LU0048580855.USD","LU0348783233.USD","LU2348773727.SGD","LU0620787316.HKD","LU1152091168.USD","HK0001040143.USD","LU0348827113.USD","LU2097828714.EUR","BK1223","LU0327786744.USD","LU0543330566.HKD","BK1149","BK1185","01377","LU0828238088.HKD","601318","00300","02899","LU1993786604.SGD","LU1242518857.USD","BK1110","LU0630378429.USD","LU0082770016.USD","BK1610","01276","LU0605514214.HKD","LU0269904917.USD","BK1205","IE00BZ08YT58.USD","BK1141","LU0762540952.USD","LU1282649067.USD","IE00BVYPNQ40.USD","HK0001040168.HKD","LU1504937902.USD","02865","BK1544","00042","LU0348814723.USD","BK1521","LU0052750758.USD","00995","03188","LU0831103253.SGD","LU0648948544.HKD","01057","02475","LU0348783662.USD","LU0348816934.USD","82846","LU1064131342.USD","IE00BF5LJ272.USD","LU0348805143.USD","LU1303224171.USD","SG9999002463.SGD","LU0531971595.HKD","LU0791591158.USD","02208","LU0228367735.SGD","LU1675838814.USD","BK1193","LU1961090484.USD","LU0348767384.USD","LU1719994722.HKD","BK1533","BK1171","LU2039709279.SGD","LU0588545904.SGD","07233","IE0032431581.USD","LU0456854461.SGD","LU0737861772.HKD","02827","HK0000352382.USD","LU0149534421.HKD","82318","LU0320764599.SGD","BK1116","LU0918141887.USD","LU1642822792.SGD","LU1235295612.USD","LU0784639295.USD","BK1214","02359","LU0348788117.USD","LU0455707207.USD","LU0029875118.USD","LU0588545730.USD","LU0516423174.USD","LU0650527681.SGD","LU1046422090.SGD","LU1244550577.SGD","LU2097828631.EUR","LU1188198961.HKD","SG9999000459.SGD","LU0572944931.SGD","SG9999002562.SGD","LU0828237510.HKD","LU0345780521.USD","LU0501845795.SGD","LU1211504680.USD","LU0516423091.SGD","LU2097828805.USD","LU0096374516.USD","LU0819121731.USD","01349","02218","LU1044875133.USD","LU1720050803.USD","LU0797268264.HKD","LU0762542818.HKD","BK1184","LU0210527791.USD","LU2097828557.USD","LU0164872284.USD","LU0456846285.SGD","IE0031814852.USD","399300","LU2399975544.HKD","BK1513","02701","SG9999004220.SGD","LU1813983027.USD","03308","LU0359201612.USD","LU0140636845.USD","IE00B031J352.USD","LU0359202008.SGD","LU0588545490.SGD","LU0049112450.USD","LU1282649141.HKD","LU1794554557.SGD","LU0181495838.USD","03678","LU2097828474.EUR","LU0469268626.HKD","LU0611395673.USD","LU0737861699.HKD","HK0000320223.HKD","HK0000306685.HKD","LU0328353924.USD","LU1282651121.HKD","BK1231","IE00BMCWC346.EUR","LU1008478684.HKD","LU2177674079.SGD","BK1163","02715","LU1146622755.USD","LU1880383440.USD","BK1505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109339300","title":"Movement Alert｜HENGRUI PHARMA Falls 3.19% in Regular Trading, Cautious Earnings Outlook and Sector Weakness Weigh on Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1109339300","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109339300?lang=en_us&edition=fundamental","pubTime":"2026-08-14 09:40","pubTimestamp":1786671632,"startTime":"0","endTime":"0","summary":"On August 14, HENGRUI PHARMA fell 3.19% in regular trading, trading at 53.3 HKD/share, with turnover of approximately 49.84 million HKD.The decline comes ahead of the company's interim results...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659213182","title":"Hengrui Pharma Gets China Nod For Inflammatory Bowel Injection Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2659213182","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659213182?lang=en_us&edition=fundamental","pubTime":"2026-08-13 10:27","pubTimestamp":1786588055,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals  has received approval from China's National Medical Products Administration to carry out clinical trials for its therapeutic biological product, SHR-7590 Injection.The injection is indicated for the treatment of inflammatory bowel diseases, ulcerative colitis and Crohn's disease, according to a Shanghai Stock Exchange filing on Thursday.The company has so far invested 32.5 million yuan in the research and development of the injection.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2580892862.HKD","LU1064131003.USD","LU2495084118.USD","BK0183","LU2097828714.EUR","LU2328871848.SGD","01276","LU0359201885.HKD","LU0359202008.SGD","LU1328615791.USD","LU2289578879.USD","LU1997245094.SGD","LU2097828557.USD","LU2097828474.EUR","BK0188","LU0405327148.USD","LU2148510915.USD","BK0196","LU1820825898.SGD","LU1781817850.SGD","LU0405327494.USD","BK1191","LU1997245177.USD","LU2097828805.USD","LU2580892789.USD","LU1580142542.USD","LU1023057109.AUD","LU1655091616.SGD","LU1997244956.HKD","LU0359201612.USD","LU1969619763.USD","BK0028","LU2488822045.USD","600276","LU2543165471.USD","BK0060","LU2097828631.EUR","LU1146622755.USD","LU1064130708.USD","BK0239","BK0012","LU1255011170.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659824561","title":"Hengrui Pharma Gets China Nod For Phase II Diabetes Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2659824561","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659824561?lang=en_us&edition=fundamental","pubTime":"2026-08-13 10:21","pubTimestamp":1786587667,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals  has received approval from China's National Medical Products Administration to conduct a Phase II clinical trial for its HRS-4729 injection in adult patients with type 2 diabetes.The drug is a triple agonist targeting GLP-1R, GIPR, and GCGR receptors, designed to improve glucose metabolism, aid weight loss, and suppress appetite.The company is already conducting a separate Phase II trial for the drug as a weight-loss treatment, according to a Shanghai Stock Exchange filing on Thursday.The company has invested about 81.6 million yuan in the research and development of the injection to date.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2495084118.USD","LU0359202008.SGD","LU1781817850.SGD","LU1997245094.SGD","LU0405327148.USD","LU2543165471.USD","LU2097828557.USD","LU1820825898.SGD","LU1969619763.USD","LU2097828631.EUR","LU2328871848.SGD","BK0028","LU1064131003.USD","LU0405327494.USD","LU1064130708.USD","LU2148510915.USD","LU2097828474.EUR","BK0196","LU1328615791.USD","600276","LU2580892789.USD","BK0012","LU2488822045.USD","BK0188","LU2580892862.HKD","LU1580142542.USD","LU0359201885.HKD","LU1655091616.SGD","LU1023057109.AUD","LU0359201612.USD","LU2289578879.USD","BK0183","LU1997245177.USD","LU1255011170.USD","BK0239","01276","LU2097828714.EUR","LU1146622755.USD","LU2097828805.USD","BK1191","BK0060","LU1997244956.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}